Associated Papers
Association of CTLA-4 exon 1(+49 A/G) polymorphism and susceptibility to SLE in Egyptian children and adolescents.
Arab F et al.
Lupus, 2026
CTLA4, PTNP22, and FOXO3A gene variants as genetic biomarkers for co-occurrence of type 1 diabetes and autoimmune thyroid diseases in the Polish population.
Cichocka E et al.
Polish Archives of Internal Medicine, 2026
Non-HLA risk variants in a type 1 diabetes pediatric population: Clinical and autoimmune profiles.
Díez Blanco M et al.
Anales De Pediatria, 2026
Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.
Adriana P et al.
Journal of Translational Medicine, 2025
Functional genetic variants in immune-checkpoint molecules and susceptibility to Nasopharyngeal carcinoma in a Tunisian case-control study.
Gharbi W et al.
Molecular Biology Reports, 2025
CTLA4 genetic variants influence immune regulation and susceptibility of HPV associated cervical cancer.
de Oliveira MC et al.
Discover Oncology, 2025
Allele frequency of CTLA-4 rs231775 (+49 A>G) gene polymorphism and its association with cancer susceptibility in the Saudi Arabian population and other ethnic groups.
Akhtar MS et al.
Cellular and Molecular Biology (noisy-le-grand, France), 2025
Germline Variants in the Immune Response-Related Genes: Possible Modifying Effect on Age-Dependent BRCA1 Penetrance in Breast Cancer Patient.
Kuligina ES et al.
Cancers, 2025
Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru.
Jaramillo-Valverde L et al.
Frontiers in Bioscience (scholar Edition), 2025
Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) gene polymorphism is associated with pulmonary tuberculosis susceptibility in a Thai population.
Tiwongsa P et al.
Tropical Biomedicine, 2025
Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy.
Seipel K et al.
Current Oncology (toronto, Ont.), 2025
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by BRCA1 mutation.
Liu J et al.
Science Advances, 2025
Assessment of the potential impact of polymorphisms in the Foxp3 and CTLA-4 genes in immune balance and disease susceptibility of primary Sjögren's syndrome.
Feng M et al.
Pharmacogenetics and Genomics, 2025
Is there a role of genetics in acute and chronic urticaria-A systematic review and meta-analysis.
Konstantinou GN et al.
Clinical and Translational Allergy, 2025
The Genetic Background of Ankylosing Spondylitis Reveals a Distinct Overlap with Autoimmune Diseases: A Systematic Review.
Zormpa T et al.
Journal of Clinical Medicine, 2025
CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
Barba A et al.
International Journal of Molecular Sciences, 2025
CTLA4 Haplotype Structures and -318 C>T (rs5742909) Genetic Variant Contribute to the Susceptibility of HPV Infection and Cervical Cancer.
de Oliveira MC et al.
Viruses, 2025
Efficacy of CLT4A variants as immunoregulatory molecules among Vitiligo patients in Saudi Arabia.
Alshammary AF et al.
Scientific Reports, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.
Kerle IA et al.
Npj Precision Oncology, 2025
Epidermal second-hit mutation in MVK gene associated with linear porokeratosis.
Zhao A et al.
Genes & Diseases, 2025
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.
Khan Z et al.
Endocrine, Metabolic & Immune Disorders Drug Targets, 2025
The Association between PTPN22 SNPs and susceptibility to type 1 diabetes: An updated meta-analysis.
Su Y et al.
Plos One, 2025
Association between CTLA4 polymorphisms and susceptibility to granulomatosis with polyangiitis.
Mohamadi A et al.
International Reviews of Immunology, 2025
Genetic architecture of primary biliary cholangitis: strong evidence for HLA and non-HLA risk loci.
Zhang M et al.
Frontiers in Immunology, 2025
STAT4 (rs7574865) Polymorphism and Serum STAT4 Levels in Rheumatoid Arthritis Susceptibility, Severity, and Treatment Response: A Case-Control Study in Iraqi Patients.
Abdalhussein AR et al.
Iranian Journal of Pathology, 2025
Circulating Cytotoxic T lymphocytes associated antigen-4 (CTLA-4) levels and CTLA-4 gene polymorphism role in head and neck squamous cell carcinoma.
Rashid HH et al.
Wiadomosci Lekarskie (warsaw, Poland : 1960), 2025
TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia.
Alqahtani M et al.
Hematology (amsterdam, Netherlands), 2024
CTLA4 genetic variants associated with urothelial bladder cancer susceptibility.
Koike A et al.
Urologic Oncology, 2024
Effect of DNA methylation at the CTLA4 gene on the clinical status of autoimmune thyroid diseases.
Ohtani H et al.
Clinical Immunology (orlando, Fla.), 2024
Association of four CTLA-4 gene polymorphisms with pemphigus risk: a systematic review, meta-analysis, and meta-regression.
Dhaouadi T et al.
The Journal of International Medical Research, 2024
Decoding the genetic influence of CT60 non-coding polymorphism in CTLA-4 gene and sCTLA-4 biomarker with rheumatoid arthritis in the Indian population.
Shamala V et al.
Molecular Biology Reports, 2024
The Role of Vitamin D Metabolism Genes and Their Genomic Background in Shaping Cyclosporine A Dosage Parameters after Kidney Transplantation.
Kotowska K et al.
Journal of Clinical Medicine, 2024
Relationship Between Cytotoxic T-Lymphocyte-associated Antigen-4: Programmed Death-1 Genes Polymorphisms and Susceptibility to Pediatric B-Cell Acute Lymphoblastic Leukemia.
Aref S et al.
Journal of Pediatric Hematology/oncology, 2024
Association of CTLA-4 (AT)n Variants in Basal Cell Carcinoma and Squamous Cell Carcinoma Patients from Western Mexico.
Rojas-Diaz JM et al.
Current Issues in Molecular Biology, 2024
Characteristics of Human Leukocyte Antigen Class II Genes in Japanese Patients with Type 1 Diabetes and Autoimmune Thyroid Disease.
Kajita R et al.
The Tohoku Journal of Experimental Medicine, 2024
Novel Genetic Variants Distinguishing Myelin Oligodendrocyte Glycoprotein-IgG-Positive From Myelin Oligodendrocyte Glycoprotein-IgG-Negative Pediatric Acute Disseminated Encephalomyelitis in Northern China.
Cui Y et al.
Pediatric Neurology, 2024
Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study.
Zhou H et al.
Discover Oncology, 2024
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.
de Joode K et al.
Journal of Immunotherapy (hagerstown, Md. : 1997), 2024
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I et al.
Journal of Translational Medicine, 2024
Immunotherapy for colorectal cancer: insight from inherited genetics.
Tjader NP et al.
Trends in Cancer, 2024
CTLA-4 expression and polymorphisms in Schizophrenia; a systematic review of literature.
Fayedeh F et al.
Molecular Biology Reports, 2024
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP).
El Demerdash DM et al.
Blood Research, 2024
Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) +49A>G (rs231775) gene polymorphism is not associated with COVID-19 severity and mortality in an Iranian population.
Mirsharif ES et al.
Heliyon, 2024
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
de Joode K et al.
Cancer Treatment Reviews, 2024
Association between CTLA4 + 49A/G polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
Tan X et al.
Nucleosides, Nucleotides & Nucleic Acids, 2024